This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Syneron Medical's Management Presents At The Lazard Capital Markets 8th Annual Healthcare Conference (Transcript)

Syneron Medical Ltd. (ELOS)

Lazard Capital Markets 8th Annual Healthcare Conference 2011

November 16, 2011 2:30 PM EST


Asaf Alperovitz – Chief Financial Officer


Unknown Analysts



Thanks for joining us. My name is Marie Thibault. I’m one of the medical technology associates here at Lazard Capital Markets. Up next is Syneron Medical and with us today is Asaf Alperovitz and he’s going to – he’s the Chief Financial Officer of the company and he’s going to give a presentation and right after that we’ll have some time for questions.

So Asaf, why don’t you take it away?

Asaf Alperovitz

Thank you. Hi everyone. Welcome to Syneron’s presentation. I will start some investment highlights, those of you who are not familiar with Syneron. So what we are is the global leader in aesthetic devices. We control 40% on a worldwide global basis market share and we’re actually growing significantly and outgrowing the market. In the second quarter of this year with 24.1%. In the second quarter which was just released last week we had growth of 28% and we have a strong momentum currently in the marketplace.

What we are, we relate ourselves on the platform of steady company. We have the largest worldwide sales, distribution and service network across 90 countries. We have 11 countries in which we operate directly and in the remaining countries we work with strong distributing partners that are working with us mostly for several years. We have a very comprehensive and diverse product portfolio. We have breadth and depth within our product portfolio and we have leadership position in the largest and fastest growing markets. We’re either number 1 or number 2 with each specific application around the world and I will have a slide specifically presenting that with different applications.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,053.32 +2.57 0.02%
S&P 500 2,013.43 +15.91 0.80%
NASDAQ 4,818.8480 +8.06 0.17%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs